| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |